Market Overview

15 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Clovis Oncology Inc (NASDAQ: CLVS) shares rose 41.6 percent to $84.89 in pre-market trading after the company reported that Rucaparib significantly improved progression-free survival in all ovarian cancer patient populations studied in Phase 3 ARIEL3 maintenance treatment trial. The company also announced a $142 million class action settlement. Chardan Capital upgraded Clovis Oncology from Sell to Neutral.
  • Rice Energy Inc (NYSE: RICE) shares rose 27.2 percent to $25.05 in pre-market trading as EQT Corporation (NYSE: EQT) announced plans to buy the company for $6.7 billion.
  • Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) rose 14 percent to $2.85 in pre-market trading after the company disclosed that its New Drug Application for TAVALISSE is accepted by the FDA.
  • Exelixis, Inc. (NASDAQ: EXEL) shares rose 4.6 percent to $20.14 in pre-market trading. IRC has confirmed that cabozantinib has significantly improved progression-free survival compared to sunitinib.
  • JD.Com Inc(ADR) (NASDAQ: JD) rose 3.6 percent to $39.54 in pre-market trading. JD.Com reported that transaction volume of 6.18 anniversary sales event rose 50 percent in the first 18 days versus first 18 days in 2016.
  • Valeant Pharmaceuticals Intl Inc (NYSE: VRX) rose 3.5 percent to $13.10 in pre-market trading after the company reported that John Paulson joined its board of directors.
  • Sprouts Farmers Market Inc (NASDAQ: SFM) rose 3.1 percent to $21.65 in pre-market trading after dropping 6.29 percent on Friday.
  • Nutanix Inc (NASDAQ: NTNX) shares rose 2.5 percent to $18.10 in pre-market trading as the company announced a partnership with Netmagic to offer managed enterprise cloud services.
  • Applied Optoelectronics Inc (NASDAQ: AAOI) shares rose 2.3 percent to $64.30 in the pre-market trading session after gaining 1.04 percent on Friday.
  • Horizon Pharma PLC (NASDAQ: HZNP) rose 2.1 percent to $10.50 in pre-market trading after the company reported Health Canada approval of PROCYSBI for the treatment of neophropathic cystinosis.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Seattle Genetics, Inc. (NASDAQ: SGEN) fell 12.1 percent to $56.75 in pre-market trading after the company disclosed that it has discontinued its Phase 3 CASCADE trial in frontline acute myeloid leukemia.
  • TESARO Inc (NASDAQ: TSRO) shares fell 11 percent to $128.50 in pre-market trading after gaining 0.06 percent on Friday.
  • EQT Corporation (NYSE: EQT) shares fell 6.4 percent to $55.00 after the company announced plans to buy Rice Energy for $6.7 billion.
  • Portola Pharmaceuticals Inc (NASDAQ: PTLA) fell around 5.3 percent to $33.20 in pre-market trading after dropping 1.13 percent on Friday.
  • IMPINJ Inc (NASDAQ: PI) shares fell 3.1 percent to $54.00 in pre-market trading after surging 19.11 percent on Friday. Morgan Stanley downgraded Impinj from Overweight to Equal-Weight.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

 

Related Articles (CLVS + AAOI)

View Comments and Join the Discussion!

Partner Center